Advertisement

GI & Endoscopy

A study published in Gastroenterology found no evidence to support claims that proton-pump inhibitors cause pneumonia, chronic kidney disease, diabetes and dementia.

Advertisement

Takeda is trying to change how gastrointestinal diseases are treated. Uthra Sundaram, senior vice president of Takeda's gastrointestinal business unit, shared insights into the company's focus on GI, its drug pipeline and how the company's acquisition of Shire has been…

Advertisement